Wang Huiming, Wang Xing, Wang Xiang, Xin Xin, Zhang Hui, Jia Shuqi, Wang Wenyuan
Department of physical education, Shanghai University of Sport, Shanghai, 200438, China.
Department of physical education, East China University of Political Science and Law, Shanghai, 201620, China.
BMC Pediatr. 2025 Jul 1;25(1):476. doi: 10.1186/s12887-025-05821-3.
To explore the effect of jumping exercises on improving short-stature symptoms and changes of serum GH, IGF-1, IGFBP-3, and IGF-1/IGFBP-3 in short-stature patients, so as to provide potential theoretical reference for short-stature treatment.
A non-randomized controlled intervention study was registered on January 8, 2025, with the China Clinical Trial Registry (ChiCTR2500095544). This study was conducted with the recruitment of 15 short-stature children in the same environment (Exercise Experimental Group 1); 20 children with normal development level (Blank Control Group 2); and 27 healthy short-stature children in this area (Short Blank Control Group 3). Children in Group 1 were given exercise intervention for 24 weeks, and those in the other two groups were provided with natural observation for 24 weeks. After the experiment, this study further analyzed the growth values of height, growth hormone (GH), insulin-like growth factor-1 (IGF-1), insulin-like growth factor-binding protein 3 (IGF-BP-3) and IGF-1/IGF-BP-3 of the three groups.
After 24 weeks of exercise intervention, Group 1 had higher height, serum IGF-1, and the growth value of molar ratio of IGF-1/IGFBP-3 than those of Group 2 and Group 3, with statistically significant difference between Group 1 and Group 3 (all p < 0.05). However, there was no significant difference in serum GH level and its growth value among groups before and after the experiment (p > 0.05),. In addition, the serum IGFBP-3 in Group 1 was lower than that in Group 2 and Group 3 (both p < 0.01).
The 24-week jumping exercise intervention can effectively improve the height of short-stature children. It can enhance the function of GH-IGF-1-IGFBP-3 axis through improving serum IGF-3 level and molar ratio of IGF-1/IGFBP-3, while decreasing the level of serum IGFBP-3. Nevertheless, exercise intervention has no effect on morning GH secretion in short-stature children.
探讨跳跃运动对改善身材矮小患者身材矮小症状及血清生长激素(GH)、胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子结合蛋白3(IGFBP-3)和IGF-1/IGFBP-3变化的影响,为身材矮小治疗提供潜在的理论参考。
2025年1月8日在中国临床试验注册中心(ChiCTR2500095544)注册了一项非随机对照干预研究。本研究招募了15名处于相同环境下的身材矮小儿童(运动实验组1);20名发育水平正常的儿童(空白对照组2);以及该地区27名健康身材矮小儿童(身材矮小空白对照组3)。对实验组1的儿童进行24周的运动干预,对其他两组儿童进行24周的自然观察。实验结束后,本研究进一步分析了三组儿童的身高、生长激素(GH)、胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子结合蛋白3(IGF-BP-3)和IGF-1/IGF-BP-3的生长值。
经过24周的运动干预,实验组1的身高、血清IGF-1以及IGF-1/IGFBP-3摩尔比的增长值均高于对照组2和对照组3,实验组1与对照组3之间差异具有统计学意义(均p<0.05)。然而,实验前后各组血清GH水平及其增长值差异无统计学意义(p>0.05)。此外,实验组1的血清IGFBP-3低于对照组2和对照组3(均p<0.01)。
24周的跳跃运动干预可有效提高身材矮小儿童的身高。它可以通过提高血清IGF-3水平和IGF-1/IGFBP-3摩尔比来增强GH-IGF-1-IGFBP-3轴的功能,同时降低血清IGFBP-3水平。然而,运动干预对身材矮小儿童早晨GH分泌无影响。